Edgewise Therapeutics EWTX
NASDAQ EWTX
$41.40 +0.92 (+2.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Edgewise Therapeutics (EWTX) Interest & Investment Income (2020 - 2026)

Updated

Edgewise Therapeutics' Interest & Investment Income came in at $4.62 million for Q2 2026, down 28.9% from $6.5 million a year earlier and down 9.5% from the prior quarter.

Analysis

Edgewise Therapeutics (EWTX) Interest & Investment Income (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Edgewise Therapeutics reported Interest & Investment Income of $21.67 million, down 9.1% year-over-year; for FY2025, it was $23.61 million, down 5.6% from FY2024.

  • Interest & Investment Income carries a five-year compound annual growth rate of 221.3% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $25.02 million in FY2024 (+76.3%), $14.19 million in FY2023 (+253.3%), $4.02 million in FY2022 (+899.5%) and $402,000 in FY2021 (+482.6%).
  • The Q2 2026 figure represents the lowest quarterly Interest & Investment Income since Q4 2023.
  • Year-over-year, Interest & Investment Income has declined for six consecutive quarters, with growth averaging 9.2% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2023 (growth of 812.7%), and the weakest in Q2 2026 (a decline of 28.9%).
  • Business Quant data shows EWTX's Interest & Investment Income at $5.1 million (Q1 2026), $5.76 million (Q4 2025) and $6.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Edgewise Therapeutics 4.46 Bn 4.46 Bn - 4.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.62 Mn
Mar 31, 2026 5.10 Mn
Dec 31, 2025 5.76 Mn
Sep 30, 2025 6.19 Mn
Jun 30, 2025 6.50 Mn
Mar 31, 2025 5.16 Mn
Dec 31, 2024 5.88 Mn
Sep 30, 2024 6.30 Mn
Jun 30, 2024 6.61 Mn
Mar 31, 2024 6.23 Mn
Dec 31, 2023 3.72 Mn
Sep 30, 2023 3.74 Mn
Jun 30, 2023 3.87 Mn
Mar 31, 2023 2.87 Mn
Dec 31, 2022 2.66 Mn
Sep 30, 2022 764,000.00
Jun 30, 2022 424,000.00
Mar 31, 2022 166,000.00
Dec 31, 2021 126,000.00
Sep 30, 2021 127,000.00
API Access

Edgewise Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EWTX&period=max&api_key=YOUR_API_KEY